Assessing the Burden of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers in Mexico City: A Data-Driven Call to Action


Por: Antonio-Villa N.E., Bello-Chavolla O.Y., Vargas-Vazquez, Arsenio, Fermin-Martinez, Carlos A., Marquez-Salinas, Alejandro, Pisanty-Alatorre, Julio, Bahena-López J.P.

Publicada: 1 jul 2021
Resumen:
Background. Healthcare workers (HCWs) could be at increased occupational risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections due to increased exposure. Information regarding the burden of coronavirus disease 2019 (COVID-19) epidemic in HCWs living in Mexico is scarce. Here, we aimed to explore the epidemiology, symptoms, and risk factors associated with adverse outcomes in HCWs in Mexico City. Methods. We explored data collected by the National Epidemiological Surveillance System in Mexico City, in HCWs who underwent real-time reverse transcription polymerase chain reaction (RT-PCR) test. We explored COVID-19 outcomes in HCWs and the performance of symptoms to detect SARS-CoV-2 infection. Results. As of 20 September 2020, 57 758 HCWs were tested for SARS-CoV-2 and 17 531 were confirmed (30.35%); 6610 were nurses (37.70%), 4910 physicians (28.0%), 267 dentists (1.52%), and 5744 laboratory personnel and other HCWs (32.76%). Overall, 2378 HCWs required hospitalization (4.12%), 2648 developed severe COVID-19 (4.58%), and 336 required mechanical-ventilatory support (.58%). Lethality was recorded in 472 (.82%) cases. We identified 635 asymptomatic SARS-CoV-2 infections (3.62%). Compared with general population, HCWs had higher incidence, testing, asymptomatic cases, and mortality rates. No individual symptom offers adequate performance to detect SARS-CoV2. Older HCWs with chronic noncommunicable diseases and severe respiratory symptoms were associated with higher risk for adverse outcome; physicians were at higher risk compared with nurses and other HCWs. Conclusions. We report a high prevalence of SARS-CoV-2 infection in HCWs in Mexico City. Symptoms as a screening method are not efficient to discern those HCWs with a positive PCR-RT test. Particular attention should focus on HCWs with risk factors to prevent adverse outcomes.

Filiaciones:
Antonio-Villa N.E.:
 Faculty of Medicine, National Autonomous University of MexicoMexico City, Mexico

Bello-Chavolla O.Y.:
 Dirección de Investigación, Instituto Nacional de GeriatríaMexico City, Mexico

Vargas-Vazquez, Arsenio:
 Faculty of Medicine, National Autonomous University of MexicoMexico City, Mexico

Fermin-Martinez, Carlos A.:
 Faculty of Medicine, National Autonomous University of MexicoMexico City, Mexico

Marquez-Salinas, Alejandro:
 Faculty of Medicine, National Autonomous University of MexicoMexico City, Mexico

Pisanty-Alatorre, Julio:
 Faculty of Medicine, National Autonomous University of MexicoMexico City, Mexico

 Instituto Mexicano del Seguro SocialMexico City, Mexico

 Public Health Department, Faculty of Medicine, National Autonomous University of MexicoMexico City, Mexico

Bahena-López J.P.:
 Faculty of Medicine, National Autonomous University of MexicoMexico City, Mexico
ISSN: 10584838





CLINICAL INFECTIOUS DISEASES
Editorial
Oxford University Press, 1427 E 60TH ST, CHICAGO, IL 60637-2954 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 73 Número: 1
Páginas: 191-198
WOS Id: 000699822100028
ID de PubMed: 32986819
imagen Green Submitted, Bronze, Green Published, Green